Scorpion raises $150M with sights on the next wave of targeted therapies
Read More
Welcome to the era of Precision Oncology 2.0™
Aiming to deliver a fast, precise and lethal strike at cancer’s unique drivers
Before we launch a program against a new, high-value target, we always ask ourselves:
Why our work matters
We are developing drugs specifically designed to interact with validated cancer targets with greater selectivity and optimized pharmaceutical properties to improve their safety and efficacy.
Meet our
leadership team
Our world-class team is comprised of experts in cancer biology, medicinal chemistry, next-generation chemical proteomics, computational chemistry and molecular biophysics, machine learning, and drug development. Together, they have architected a new and innovative approach to target and drug discovery.
News
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Read More
Growing a thriving culture
The work environment we have created is as important to us as our science. We are looking for team members who share our cultural commitments.